Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stéphanie Struski

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Annals of Hematology|December 30, 2011
Chronic lymphocytic leukemia and prolymphocytic leukemia with MYC translocations: a subgroup with an aggressive disease courseNatalie Put, Katrien Van Roosbroeck, Peter Konings, et al.
Journal of Cellular and Molecular Medicine|September 7, 2021
Myeloid malignancies with translocation t(4;12)(q11-13;p13): molecular landscape, clonal hierarchy and clinical outcomesVincent Parinet, Elise Chapiro, Audrey Bidet, et al.
Haematologica|October 16, 2012
Chromosomal aberrations and their prognostic value in a series of 174 untreated patients with Waldenström's macroglobulinemiaFlorence Nguyen-Khac, Jerome Lambert, Elise Chapiro, et al.
British Journal of Haematology|November 5, 2011
PRDM16 (1p36) translocations define a distinct entity of myeloid malignancies with poor prognosis but may also occur in lymphoid malignanciesFrancois P Duhoux, Geneviève Ameye, Carmen P Montano-Almendras, et al.
American Journal of Blood Research|March 21, 2012
Specific chromosomal IG translocations have different prognoses in chronic lymphocytic leukemiaFlorence Nguyen-Khac, Elise Chapiro, Claude Lesty, et al.
American Journal of Hematology|December 2, 2017
"Double-hit" chronic lymphocytic leukemia: An aggressive subgroup with 17p deletion and 8q24 gainElise Chapiro, Claude Lesty, Clémentine Gabillaud, et al.
British Journal of Haematology|December 14, 2020
Clinical and biological features of B-cell neoplasms with CDK6 translocations: an association with a subgroup of splenic marginal zone lymphomas displaying frequent CD5 expression, prolymphocytic cells, and TP53 abnormalitiesBaptiste Gailllard, Pascale Cornillet-Lefebvre, Quoc-Hung Le, et al.
Haematologica|December 22, 2018
Poor prognosis of chromosome 7 clonal aberrations in Philadelphia-negative metaphases and relevance of potential underlying myelodysplastic features in chronic myeloid leukemiaAudrey Bidet, Stéphanie Dulucq, Thomas Smol, et al.
Plos One|November 1, 2011
Refinement of 1p36 alterations not involving PRDM16 in myeloid and lymphoid malignanciesFrancois P Duhoux, Geneviève Ameye, Virginie Lambot, et al.
Blood|December 16, 2006
Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL)Takashi Akasaka, Theodore Balasas, Lisa J Russell, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Annals of Hematology|December 30, 2011
Chronic lymphocytic leukemia and prolymphocytic leukemia with MYC translocations: a subgroup with an aggressive disease courseNatalie Put, Katrien Van Roosbroeck, Peter Konings, et al.
Journal of Cellular and Molecular Medicine|September 7, 2021
Myeloid malignancies with translocation t(4;12)(q11-13;p13): molecular landscape, clonal hierarchy and clinical outcomesVincent Parinet, Elise Chapiro, Audrey Bidet, et al.
Haematologica|October 16, 2012
Chromosomal aberrations and their prognostic value in a series of 174 untreated patients with Waldenström's macroglobulinemiaFlorence Nguyen-Khac, Jerome Lambert, Elise Chapiro, et al.
British Journal of Haematology|November 5, 2011
PRDM16 (1p36) translocations define a distinct entity of myeloid malignancies with poor prognosis but may also occur in lymphoid malignanciesFrancois P Duhoux, Geneviève Ameye, Carmen P Montano-Almendras, et al.
American Journal of Blood Research|March 21, 2012
Specific chromosomal IG translocations have different prognoses in chronic lymphocytic leukemiaFlorence Nguyen-Khac, Elise Chapiro, Claude Lesty, et al.
American Journal of Hematology|December 2, 2017
"Double-hit" chronic lymphocytic leukemia: An aggressive subgroup with 17p deletion and 8q24 gainElise Chapiro, Claude Lesty, Clémentine Gabillaud, et al.
British Journal of Haematology|December 14, 2020
Clinical and biological features of B-cell neoplasms with CDK6 translocations: an association with a subgroup of splenic marginal zone lymphomas displaying frequent CD5 expression, prolymphocytic cells, and TP53 abnormalitiesBaptiste Gailllard, Pascale Cornillet-Lefebvre, Quoc-Hung Le, et al.
Haematologica|December 22, 2018
Poor prognosis of chromosome 7 clonal aberrations in Philadelphia-negative metaphases and relevance of potential underlying myelodysplastic features in chronic myeloid leukemiaAudrey Bidet, Stéphanie Dulucq, Thomas Smol, et al.
Plos One|November 1, 2011
Refinement of 1p36 alterations not involving PRDM16 in myeloid and lymphoid malignanciesFrancois P Duhoux, Geneviève Ameye, Virginie Lambot, et al.
Blood|December 16, 2006
Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL)Takashi Akasaka, Theodore Balasas, Lisa J Russell, et al.
Pageof 3